Are you Dr. Harmon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Yaw 7
Mass General Hospital
Boston, MA 02114Phone+1 617-726-8748Fax+1 617-726-2894
Summary
- Dr. David Harmon, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Assistant Professor at Harvard Medical School.
Education & Training
Harvard Medical SchoolClass of 1974
Certifications & Licensure
MA State Medical License 1979 - 2019
Clinical Trials
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall Start of enrollment: 2004 Jun 17
Publications & Presentations
PubMed
- 235 citationsMulticenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor SarcomasSuzanne George, Priscilla Merriam, Robert G. Maki, Annick D. Van den Abbeele, Jeffrey T. Yap
Journal of Clinical Oncology. 2009-07-01 - 89 citationsβ-Catenin Mutation Status and Outcomes in Sporadic Desmoid TumorsJohn T. Mullen, Thomas F. DeLaney, Andrew E. Rosenberg, Long P. Le, A. John Iafrate
The Oncologist. 2013-09-01 - 91 citationsDesmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical SeriesJohn T. Mullen, Thomas F. DeLaney, Wendy Kobayashi, Jackie Szymonifka, Beow Y. Yeap
Annals of Surgical Oncology. 2012-09-11
